AQUILA BIOMEDICAL LIMITED

AQUILA BIOMEDICAL LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameAQUILA BIOMEDICAL LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number SC393914
    JurisdictionScotland
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of AQUILA BIOMEDICAL LIMITED?

    • Dormant Company (99999) / Activities of extraterritorial organisations and bodies

    Where is AQUILA BIOMEDICAL LIMITED located?

    Registered Office Address
    2 James Lindsay Place
    DD1 5JJ Dundee
    Scotland
    Undeliverable Registered Office AddressNo

    What are the latest accounts for AQUILA BIOMEDICAL LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2024
    Next Accounts Due OnSep 30, 2025
    Last Accounts
    Last Accounts Made Up ToDec 31, 2023

    What is the status of the latest confirmation statement for AQUILA BIOMEDICAL LIMITED?

    Last Confirmation Statement Made Up ToMar 17, 2026
    Next Confirmation Statement DueMar 31, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMar 17, 2025
    OverdueNo

    What are the latest filings for AQUILA BIOMEDICAL LIMITED?

    Filings
    DateDescriptionDocumentType

    Appointment of Dr Benjamin Cliff as a director on Jul 29, 2025

    2 pagesAP01

    Termination of appointment of Benjamin Cliff as a director on Jul 27, 2025

    1 pagesTM01

    Appointment of Mr Jonathan Timothy Critchley as a director on Jul 29, 2025

    2 pagesAP01

    Confirmation statement made on Mar 17, 2025 with updates

    3 pagesCS01

    Accounts for a dormant company made up to Dec 31, 2023

    11 pagesAA

    Confirmation statement made on Mar 31, 2024 with no updates

    3 pagesCS01

    Audit exemption subsidiary accounts made up to Dec 31, 2022

    20 pagesAA

    legacy

    183 pagesPARENT_ACC

    legacy

    1 pagesAGREEMENT2

    legacy

    3 pagesGUARANTEE2

    legacy

    1 pagesAGREEMENT2

    legacy

    3 pagesGUARANTEE2

    legacy

    1 pagesAGREEMENT2

    Confirmation statement made on Mar 31, 2023 with no updates

    3 pagesCS01

    Director's details changed for Dr Benjamin Cliff on Mar 31, 2023

    2 pagesCH01

    Director's details changed for Dr Benjamin Cliff on Mar 31, 2023

    2 pagesCH01

    Termination of appointment of Mark Carnegie-Brown as a director on Mar 31, 2023

    1 pagesTM01

    Termination of appointment of Steven Blair as a director on Mar 31, 2023

    1 pagesTM01

    Appointment of Dr Benjamin Cliff as a director on Mar 31, 2023

    2 pagesAP01

    Audit exemption subsidiary accounts made up to Dec 31, 2021

    22 pagesAA

    legacy

    206 pagesPARENT_ACC

    legacy

    1 pagesAGREEMENT2

    legacy

    3 pagesGUARANTEE2

    Termination of appointment of Steven Francis Axtell Horder as a director on Aug 30, 2022

    1 pagesTM01

    Appointment of Mr Steven Blair as a director on Aug 30, 2022

    2 pagesAP01

    Who are the officers of AQUILA BIOMEDICAL LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    CLIFF, Benjamin, Dr
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    Director
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    EnglandBritishChief Executive309042890001
    CRITCHLEY, Jonathan Timothy
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    Director
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    EnglandBritishChief Financial Officer328643350001
    ANDERTON, Stephen Mark, Professor
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    Director
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    United KingdomBritishScientist157936600001
    BLAIR, Steven
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    Director
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    United KingdomBritishVice President Of Operations299848800001
    BOA, Simon Andrew, Non-Executive Director
    c/o Mcgrigors
    1 Earl Grey Street
    EH3 9QA Edinburgh
    Princes Exchange
    Midlothian
    Uk
    Director
    c/o Mcgrigors
    1 Earl Grey Street
    EH3 9QA Edinburgh
    Princes Exchange
    Midlothian
    Uk
    U.K.BritishDirector Of Business Development And Marketing185432820001
    CARNEGIE-BROWN, Mark, Dr
    Block 35s Alderley Park
    SK10 4TG Macclesfield
    C/O Concept Life Sciences
    Cheshire
    United Kingdom
    Director
    Block 35s Alderley Park
    SK10 4TG Macclesfield
    C/O Concept Life Sciences
    Cheshire
    United Kingdom
    United KingdomBritishPresident224430380001
    CLIFF, Benjamin, Dr
    25-27 Buckingham Palace Road
    SW1W 0PP London
    Warwick House
    England
    Director
    25-27 Buckingham Palace Road
    SW1W 0PP London
    Warwick House
    England
    EnglandBritishDirector307555740001
    DORIS, Clare Louise
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    Director
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    United KingdomBritishCompany Director202558000001
    FORT, Michael John
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    Director
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    United KingdomBritishDirector189303790003
    HANDLEY, John William
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    Director
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    United KingdomBritishDirector236950100001
    HANSON, Matthew James
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    Director
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    United KingdomBritishChief Financial Officer, Concept Life Sciences276583410001
    HORDER, Steven Francis Axtell
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    Director
    James Lindsay Place
    DD1 5JJ Dundee
    2
    Scotland
    EnglandBritishDirector271429910002
    MARRIAGE, Howard John, Dr
    Little France Road
    EH16 4UX Edinburgh
    Nine The Bioquarter
    Scotland
    Director
    Little France Road
    EH16 4UX Edinburgh
    Nine The Bioquarter
    Scotland
    United KingdomBritishDirector65745150002
    MCCLUSKEY, Paul
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    Director
    St Peters Square
    M2 3DE Manchester
    One
    United Kingdom
    United KingdomBritishDirector156519370001
    TEMPLETON, Alison Gibson Boyd
    Rosebank
    EH54 7EG Livingston
    The Alba Campus
    West Lothian
    Scotland
    Director
    Rosebank
    EH54 7EG Livingston
    The Alba Campus
    West Lothian
    Scotland
    ScotlandBritishDirector168287260001
    WADDELL, John Maclaren Ogilvie
    Little France Road
    EH16 4UX Edinburgh
    Nine The Bioquarter
    Director
    Little France Road
    EH16 4UX Edinburgh
    Nine The Bioquarter
    ScotlandBritishCompany Director113233140001

    Who are the persons with significant control of AQUILA BIOMEDICAL LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    St. Peter's Square
    M2 3DE Manchester
    One
    United Kingdom
    Oct 23, 2017
    St. Peter's Square
    M2 3DE Manchester
    One
    United Kingdom
    No
    Legal FormPrivate Company Limited By Shares
    Country RegisteredEngland And Wales
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies House
    Registration Number09046575
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Professor Stephen Anderton
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    Apr 06, 2016
    Exchange Tower
    19 Canning Street
    EH3 8EH Edinburgh
    Addleshaw Goddard Llp
    United Kingdom
    Yes
    Nationality: British
    Country of Residence: Scotland
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0